Literature DB >> 1505760

Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study.

S Daniele1, J P Gilbard, C L Schepens.   

Abstract

We report three patients with persistent epithelial defects in the context of neurotrophic keratopathy that healed while on treatment with topically applied, mouse-derived epidermal growth factor (m-EGF). The clinical course of these patients was striking and suggests that EGF may have a potential role in the treatment of persistent epithelial defects in subjects suffering from neurotrophic keratitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505760     DOI: 10.1007/bf00165937

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse.

Authors:  S COHEN; G A ELLIOTT
Journal:  J Invest Dermatol       Date:  1963-01       Impact factor: 8.551

2.  Mitotic and wound-healing activities of the corneal epithelium; effect of sensory denervation.

Authors:  S SIGELMAN; J S FRIEDENWALD
Journal:  AMA Arch Ophthalmol       Date:  1954-07

Review 3.  Prospects for epidermal growth factor in the management of corneal disorders.

Authors:  R C Tripathi; S C Raja; B J Tripathi
Journal:  Surv Ophthalmol       Date:  1990 May-Jun       Impact factor: 6.048

4.  Tear film and ocular surface changes in a rabbit model of neurotrophic keratitis.

Authors:  J P Gilbard; S R Rossi
Journal:  Ophthalmology       Date:  1990-03       Impact factor: 12.079

5.  Effect of topically administered epidermal growth factor on corneal wound strength.

Authors:  H M Leibowitz; S Morello; M Stern; A Kupferman
Journal:  Arch Ophthalmol       Date:  1990-05

6.  Presence of epidermal growth factor in human tears.

Authors:  Y Ohashi; M Motokura; Y Kinoshita; T Mano; H Watanabe; S Kinoshita; R Manabe; K Oshiden; C Yanaihara
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

7.  Epidermal growth factor is a constant component of normal human tear fluid.

Authors:  G B van Setten; L Viinikka; T Tervo; K Pesonen; A Tarkkanen; J Perheentupa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

8.  Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea.

Authors:  L Frati; S Daniele; A Delogu; I Covelli
Journal:  Exp Eye Res       Date:  1972-09       Impact factor: 3.467

Review 9.  The epidermal growth factor (EGF).

Authors:  S Cohen
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

10.  The effect of the epidermal growth factor (EGF) on the corneal epithelium in humans.

Authors:  S Daniele; L Frati; C Fiore; G Santoni
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-05-07
View more
  5 in total

Review 1.  Diagnosis and management of neurotrophic keratitis.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2014-03-19

2.  Pigment Epithelium-Derived Factor Peptide Promotes Corneal Nerve Regeneration: An In Vivo and In Vitro Study.

Authors:  Shu-I Yeh; Sung-Hsun Yu; Hsiao-Sang Chu; Chin-Te Huang; Yeou-Ping Tsao; Chao-Min Cheng; Wei-Li Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

Review 3.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

Review 4.  Neurotrophic factors and corneal nerve regeneration.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

5.  Effect of epidermal growth factor ointment on persistent epithelial defects of the cornea.

Authors:  Hyun Sik Moon; Lan Li; Hyeon Jeong Yoon; Yong Sok Ji; Kyung Chul Yoon
Journal:  BMC Ophthalmol       Date:  2020-04-15       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.